Kort præsentation

My research interests include regulatory science of medicines and digital health technologies, European pharmaceutical governance and policy, regulatory theory, and regulatory science in society. With my research I pursue the dual aim of providing evidentiary basis for regulatory decision-making (particularly in risk minimization) as well as provide critical analyses of regulatory science from a societal perspective.

I am currently involved with three research projects

Regulatory science of medicinal risk minimization measures

This research addresses issues in postmarketing risk-benefit communication and employs qualitative empirical methods to examine regulatory practices, such as risk-benefit communication and evaluation approaches.

Gravitate Health: Futures of digital drug safety information

Gravitate Health is an IMI public-private partnership project aimed at improving digital drug information accessibility and patient engagement through European health solutions and ePI integration.

Perceptions and engagement with EU regulation of digital medical devices

This research project examines stakeholders’ engagement and perceptions of new regulations and institutions for health apps and digital devices.